Similar articles for PMID: 20525837

Year	Number of Results
2002	1
2003	2
2004	1
2005	7
2006	7
2007	12
2008	13
2009	7
2010	17
2011	8
2012	7
2013	8
2014	6
2015	3
2016	4
2018	2
2020	4
2021	4
2024	0

1

Mixed response to tocilizumab for ankylosing spondylitis.

Henes JC, Horger M, Guenaydin I, Kanz L, Koetter I. Henes JC, et al. Ann Rheum Dis. 2010 Dec;69(12):2217-8. doi: 10.1136/ard.2009.126706. Epub 2010 Jun 4. Ann Rheum Dis. 2010. PMID: 20525837 No abstract available.

2

Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.

Haibel H, Rudwaleit M, Brandt HC, Grozdanovic Z, Listing J, Kupper H, Braun J, Sieper J. Haibel H, et al. Arthritis Rheum. 2006 Feb;54(2):678-81. doi: 10.1002/art.21563. Arthritis Rheum. 2006. PMID: 16447247 Free article. Clinical Trial. No abstract available.

3

Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.

Rudwaleit M. Rudwaleit M. J Rheumatol. 2010 Aug 1;37(8):1553-5. doi: 10.3899/jrheum.100422. J Rheumatol. 2010. PMID: 20675850 No abstract available.

4

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists.

Brulhart L, Nissen MJ, Chevallier P, Gabay C. Brulhart L, et al. Joint Bone Spine. 2010 Dec;77(6):625-6. doi: 10.1016/j.jbspin.2010.08.004. Epub 2010 Sep 20. Joint Bone Spine. 2010. PMID: 20851032 No abstract available.

5

Intraarticular injection of infliximab.

Sakellariou GT, Kakavouli G, Chatzigiannis I. Sakellariou GT, et al. J Rheumatol. 2006 Sep;33(9):1912-3; author reply 1913. J Rheumatol. 2006. PMID: 16960955 No abstract available.

6

The HLA-B*2709 subtype in a woman with early ankylosing spondylitis.

Olivieri I, D'Angelo S, Scarano E, Santospirito V, Padula A. Olivieri I, et al. Arthritis Rheum. 2007 Aug;56(8):2805-7. doi: 10.1002/art.22821. Arthritis Rheum. 2007. PMID: 17665436 Free article. No abstract available.

7

Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.

Appel H, Hermann KG, Althoff CE, Rudwaleit M, Sieper J. Appel H, et al. J Rheumatol. 2007 Dec;34(12):2497-8. J Rheumatol. 2007. PMID: 18061968 No abstract available.

8

When less is more.

Deodhar A. Deodhar A. J Rheumatol. 2010 Jun;37(6):1089-90. doi: 10.3899/jrheum.100333. J Rheumatol. 2010. PMID: 20516035 No abstract available.

9

Therapeutic controversies: tumor necrosis factor α inhibitors in ankylosing spondylitis.

Song IH, Maksymowych WP. Song IH, et al. Rheum Dis Clin North Am. 2012 Aug;38(3):613-33. doi: 10.1016/j.rdc.2012.08.004. Epub 2012 Sep 15. Rheum Dis Clin North Am. 2012. PMID: 23083759 Review.

10

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation.

de Vries MK, Brouwer E, van der Horst-Bruinsma IE, Spoorenberg A, van Denderen JC, Jamnitski A, Nurmohamed MT, Dijkmans BA, Aarden LA, Wolbink GJ. de Vries MK, et al. Ann Rheum Dis. 2009 Nov;68(11):1787-8. doi: 10.1136/ard.2009.109702. Ann Rheum Dis. 2009. PMID: 19822712 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year